돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1889080생성일: 2026년 10월 25일

Pyrazine-2-Carboxylic Acid Hydrazide → 7-[(2,4-Dichloro-3-fluorophenyl)carbonyl]-3-(2-pyrazinyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine

https://huagongshe.com/reaction/1889080

반응식

참여 물질

역할이름HCID투입량
반응물Pyrazine-2-Carboxylic Acid HydrazideHCID 258796—
반응물Triethyloxonium tetrafluoroborateHCID 2723982—
반응물4-[(2,4-Dichloro-3-fluorophenyl)carbonyl]-2-piperazinoneHCID 66599361—
용매DichloromethaneHCID 6344—
생성물7-[(2,4-Dichloro-3-fluorophenyl)carbonyl]-3-(2-pyrazinyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazineHCID 66598977—

반응 단계

To a solution of 4-[(2,4-dichloro-3-fluorophenyl)carbonyl]-2-piperazinone (I37) (0.146 g, 0.5 mmol) in Dichloromethane (DCM) (3 mL) was added triethyloxonium tetrafluoroborate (0.100 g, 0.525 mmol). The solution was then stirred, under argon, for 10 minutes before 2-pyrazinecarbohydrazide (commercially available from e.g. TimTec, J& W PharmLab and Akos Consulting, 0.083 g, 0.600 mmol) was added. The solution was then stirred for a further hour before the solvent was concentrated and n-butanol (3.00 mL) was added. The solution was then stirred, under argon and reflux, for 3 hours before being cooled to room temperature. The solvent was then evaporated in vacuo and the remaining residue was purified by flash chromatography (Biotage SP4, 25M cartridge) with a gradient of 0-10% 2M NH3/MeOH in DCM. TLC confirmed product location and the solvent from the combined fractions was evaporated in vacuo. The remaining residue was then further purified by mass-direct automated HPLC, before the solvent was again evaporated in vacuo. The remaining solid was then triturated in ether before being dried in a vac-oven to yield the product in 0.056 g.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08501946B2
출처 데이터셋uspto-grants-2013_08
ORD IDord-3b6d521a11e841ac989f192d4d123ed4
출처 메모uspto-grants-2013_08